Long-term Evaluation of the Hepatitis B vaccine (Heptavax-B) in Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 11, Issue 4, 1988, Pages 326-331

  Pasko, Mary T ^a,b   Bartholomew, William R ^a,b   Beam, Thomas R ^a,b   Amsterdam, Daniel ^a,b   Cunningham, Eugene E ^a,b  

^a ERIE COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

hemodialysis patients; Hepatitis B vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; PREVENTION;

EID: 0023683805     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(88)80138-0     Document Type: Article

References (13)

1. Hepatitis B infection: A point-prevalence study in 15 US hemodialysis centers
2. Hepatitis B vaccine in patients receiving hemodialysis: Immunogenicity and efficacy
3. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): A final report
4. Inactivated hepatitis B virus vaccine
5. Hepatitis B vaccine in health care personnel
6. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine
7. Suboptimal response to hepatitis B vaccine given by injection into the buttock
8. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men
9. Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine (Heptavax-B)
10. Hepatitis B vaccine in medical staff: Efficacy and subtype crossprotection